Abstract
The in vitro biotransformation of sildenafil to its major circulating metabolite, UK-103,320, was studied in human liver microsomes and in microsomes containing heterologously expressed human cytochromes. In human liver microsomes, the meanKm (±S.E.) was 14.4 ± 2.0 μM. A screen of the chemical inhibitors omeprazole (10 μM), quinidine (10 μM), sulfaphenazole (10 μM), and ketoconazole (2.5 μM) only revealed detectable inhibition with ketoconazole. Sildenafil biotransformation (36 μM) was inhibited by increasing concentrations of ketoconazole and ritonavir (IC50 values less than 0.02 μM), which are established cytochrome P450 (CYP) 3A4 inhibitors. Using microsomes containing cDNA-expressed cytochromes, UK-103,320 formation was found to be mediated by four cytochromes: CYP3A4, -2C9, -2C19, and -2D6. Estimated relative contributions to net intrinsic clearance were 79% for CYP3A4 and 20% for CYP2C9; for CYP2C19 and -2D6, estimated contributions were less than 2%. These results demonstrate that CYP3A4 is the primary cytochrome mediating UK-103,320 formation and that drugs that inhibit CYP3A4 are likely to impair sildenafil biotransformation.
Footnotes
-
Send reprint requests to: Dr. David J. Greenblatt, Dept. of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111. E-mail:DJ.Greenblatt{at}tufts.edu
-
This work was supported in part by grants MH34223, MH01237, and RR00054 from the Department of Health and Human Services.
- Abbreviations used are::
- CYP
- cytochrome, P450
- Km
- substrate concentration corresponding to 50% Vmax
- Ks
- uncompetitive substrate inhibition constant
- Received August 20, 1999.
- Accepted December 17, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|